Screening for preclinical disease: Test and disease characteristics

American Journal of Roentgenology

Volumn 179, Issue 4, 2002, Pages 825-831

  Herman, Cheryl R ^a   Gill, Harmindar K ^a   Eng, John ^a   Fajardo, Laurie L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; EVALUATION; HUMAN; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SCREENING TEST;

EID: 0036783750     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.4.1790825     Document Type: Review

References (44)

1. Eddy DM. How to think about screening. In: Eddy DM, ed. Common screening tests, 1st ed. Philadelphia: American College of Physicians, 1991:1-21
2. Eddy DM. Screening for cervical cancer. In: Eddy DM, ed. Common screening tests, 1st ed. Philadelphia: American College of Physicians, 1991:255-285
3. Eddy DM. Screening for breast cancer. In: Eddy DM, ed. Common screening tests, 1st ed. Philadelphia: American College of Physicians, 1991:229-254
4. Garber AM, Sox HC Jr, Littenberg B. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med 1989;110:622-639
5. Sox HC Jr. Garber AM, Littenberg B. The resting electrocardiogram as a screening test: a clinical analysis. Ann Intern Med 1989;111:489-502
6. Sox HC Jr, Littenberg B, Garber AM. The role of exercise testing in screening for coronary artery disease. Ann Intern Med 1989;110:456-469
7. Smith RA, Mettlin CJ, Johnston DK, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000;50:34-49
8. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105
9. Kaneko M, Eguchi K. Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802
10. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;1123:594-642
11. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-1961
12. Black WC, Welch HG. Screening for disease. AJR 1997;168:3-11
13. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst 1980;64:1263-1272
14. Bassett LW, Lui TH, Giuliano AE, Gold RH. Prevalence of carcinoma in palpable vs. impalpable, mammographically detected lesions. AJR 1991;151:21-24
15. Morrison AS. Screening in chronic disease. New York: Oxford Univ. Press, 1992:125-127
16. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982;49:751-758
17. Rosen PP, Braun DW Jr, Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer 1980;46:919-925
18. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. N Engl J Med 1986;315:1394-1397
19. Montie JE, Wood DP Jr, Pontes E, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cytoprostatectomy specimens removed for bladder cancer. Cancer 1989;63:381-385
20. Kerlikowske K, Grady D, Barclay J, Frankel SD, Ominsky SH, et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst 1998;90:1801-1809
21. Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in radiologists' interpretations of mammograms. N Engl J Med 1994;331:1493-1499
22. Beam CA, Layde PM, Sullivan DC. Variability in the interpretation of screening mammograms by U.S. radiologists: findings from a national sample. Arch Intern Med 1996;156:209-213
23. American College of Radiology. Breast imaging reporting and data system (BI-RADS), 3rd ed. Reston, VA: American College of Radiology, 1998
24. Dixon AK, Dendy P. Spiral CT: how much does radiation dose matter? Lancet 1998;352:1082-1083
25. Faulkner K, Moores BM. Radiation dose and somatic risk from computed tomography. Acta Radiol 1987;28:483-488
26. Mossman KL. Analysis of risk in computerized tomography and other diagnostic radiology procedures. Comput Radiol 1982;6:251-256
27. Greenlick MR, Bailey JW, Wild J, Grover J. Characteristics of men most likely to respond to an invitation to be screened. Am J Public Health 1979;69:1011-1016
28. Wilhelmsen L, Ljungberg S, Wedel H, Werko L. A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis 1976;29:331-339
29. Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little Brown, 1985:172-176
30. Hutchison GB, Shapiro S. Lead time gained by diagnostic screening for breast cancer. J Natl Cancer Inst 1968;41:665-681
31. Morrison AS. The effects of early treatment, lead time, and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol 1982;111:261-267
32. Shapiro S, Goldberg JD, Hutchison GB. Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol 1974;100:357-366
33. Prorok PC. The theory of periodic screening. I. Lead time and proportion detected. Adv Appl Prob 1976;8:127-143
34. Prorok PC. The theory of periodic screening. II. Doubly bounded recurrence times and mean lead time and detection probability estimation. Adv Appl Prob 1976;8:460-476
35. Black WC, Welch HG. Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-1243
36. Shwartz M. Estimates of lead time and length time bias in a breast cancer screening program. Cancer 1980;46:844-851
37. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-1733
38. Morrison AS. Case definition in case-control studies of the efficacy of screening. Am J Epidemiol 1982;115:6-8
39. Weiss NS. Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol 1983;116:457-460
40. Morrison AS. The effects of early treatment, lead time, and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol 1982;111:261-267
41. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39[suppl 6]:2772-2782
42. Nease RF, Tsai R, Hynes LH, Littenberg B. Automated utility assessment of global health. Qual Life Res 1996;5:175-182
43. De Koning HJ, Ineveld BM, van Oortmarssen GJ, et al. Breast cancer screening and cost effectiveness: policy alternatives, quality of life considerations, and the possible impact of uncertain factors. Int J Cancer 1991;49:531-537
44. Black WC, Welch HG. A Markov model of early diagnosis. Acad Radiol 1996;3[suppl 1]:S10-S12